Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy. - Wikidata - awgldk - TriplyDB

Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy.

Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy.

http://www.wikidata.org/entity/Q36975028

about

Serum C-reactive protein concentrations in Nova Scotia Duck Tolling Retrievers with immune-mediated rheumatic disease.Autologous Bone Marrow-Derived Mesenchymal Stem Cells Modulate Molecular Markers of Inflammation in Dogs with Cruciate Ligament Rupture.Measurement of serum C-reactive protein concentration for discriminating between suppurative arthritis and osteoarthritis in dogs Synovial fluid total protein concentration as a possible marker for canine idiopathic polyarthritis.Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.Clinical features and pathological joint changes in dogs with erosive immune-mediated polyarthritis: 13 cases (2004-2012).Serum levels of innate immunity cytokines are elevated in dogs with metaphyseal osteopathy (hypertrophic osteodytrophy) during active disease and remission.A comparison of serum and plasma cytokine values using a multiplexed assay in cats.Evaluation of C-reactive protein as an inflammatory marker of pemphigus foliaceus and superficial pyoderma in dogs.Serum C-reactive protein and S100A12 concentrations in dogs with hepatic disease.Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease.Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: general recommendations.

P2860

Q33568289-CBC8710B-EAC7-458D-8971-01614ADE0DFA Q36116711-B4857686-1AD7-4E36-A3B7-D5EDC65D3E53 Q36177689-E2C8F24F-F838-4665-99AF-1E6B96517A88 Q36456581-AE93E1D7-1BBF-4B23-A97F-2064979E4450 Q37384789-503BA568-2ED4-4DEE-AB61-739625982FDA Q37674743-A8936C70-FC01-4A98-BF5C-F4C1DDE1342A Q41513184-4DD4428A-7A26-4D13-842E-6DB81B95F1E5 Q44868262-F70D9627-2DB3-453C-BBED-B95B25E4C46E Q47371590-ED95BAF4-B325-44AB-BD1B-A0F370D4BE53 Q51715946-512972F2-29AF-45E6-90A1-EB29D030BF08 Q54942768-5D378173-477E-4A10-9349-9A86B4EF9581 Q55383118-3D3D141C-1D15-4CC5-AA79-A73CC99A329E

P2860

Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy.

http://www.wikidata.org/entity/Q36975028

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Serum biomarkers of clinical a ...... mune-mediated polyarthropathy.

@en

type

label

Serum biomarkers of clinical a ...... mune-mediated polyarthropathy.

@en

prefLabel

Serum biomarkers of clinical a ...... mune-mediated polyarthropathy.

@en

P1433

Q36975028-105E6CD6-87B2-4145-9ACD-A29B3FA1C5E8

P1476

Q36975028-F1CCA9DD-33C5-4793-8DCF-1CB98DC94C44

P2093

Q36975028-38E051F4-5C15-4ACA-8509-D293A3F0B1C0

Q36975028-4A01F34B-1B9E-46A8-959B-068D9F36E400

Q36975028-624EE971-E7D7-4B67-B35D-EA9D7B85C7E3

Q36975028-7A658464-D6D6-4699-889E-E5301E81747B

Q36975028-9785E180-F9F2-4FD4-BF94-A09FDCC37803

P2860

Q36975028-03046737-3C08-4DD6-BC47-F39BD2B39A2B

Q36975028-0F180194-BE2A-429F-A8F5-5C6CDD542612

Q36975028-13631E38-D4C6-48C9-9C61-ADEABC706D4D

Q36975028-16554C76-D13F-4533-9332-4428CF75736F

Q36975028-20C7DF00-615A-43FA-810F-757333675B29

Q36975028-306C437A-09DA-4459-AFBD-3B8049755817

Q36975028-30D9DFAD-8F2C-464A-BB0A-371F93777661

Q36975028-3222783C-67E3-45B1-A8EB-E98BCAAA3DDB

Q36975028-3258E9E7-4F6A-4ACB-874B-B789C55ED55B

Q36975028-3DB7A8AF-A06C-4CD3-B35F-D818B6BF6847

P304

Q36975028-405E7127-6B6A-43A2-9F85-DEF78963E2C8

P31

Q36975028-0CDEB75D-266D-4ADF-8CFE-D73A4ECC1829

P356

Q36975028-CEF219CD-42B7-417C-BD97-D58EBA62C7A2

P433

Q36975028-84C26064-E693-4F0D-A7C7-54CD12DAE6D3

P478

Q36975028-55C6FA1B-C946-42FE-A72D-5CC248F1962D

P50

Q36975028-B97CA9E3-3A43-4EBB-98CA-B7840EF6A7E4

P577

Q36975028-01C2CB21-3D3D-46AD-8AEF-4B874AFA0153

P5875

Q36975028-8F040DB4-A229-4B93-8293-465896080CB7

P698

Q36975028-A6A2D090-5410-4F61-B616-78765BEBB8CB

P921

Q36975028-6E1EA6F7-2515-4F58-A34A-A99AA48863EE

P932

Q36975028-34DC5289-42B3-4A0E-B109-8B874877E2E5

P356

P1433

Journal of Veterinary Internal Medicine

P1476

Serum biomarkers of clinical a ...... mune-mediated polyarthropathy.

@en

P2093

J D Foster

http://www.w3.org/2001/XMLSchema#string

K Watson

http://www.w3.org/2001/XMLSchema#string

L A Trepanier

http://www.w3.org/2001/XMLSchema#string

R Kohler

http://www.w3.org/2001/XMLSchema#string

S Sample

http://www.w3.org/2001/XMLSchema#string

P2860

C-reactive protein concentration in dogs with various diseases.

Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis.

Evaluation of optimal sampling interval for activity monitoring in companion dogs.

Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis.

The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis

Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report.

C-reactive protein as an indicator of inflammatory responses to experimentally induced cystitis in dogs.

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.

Canine immune-mediated polyarthritis: clinical and laboratory findings in 83 cases in western Canada (1991-2001).

Canine immune-mediated polyarthritis: part 1: pathophysiology.

P304

905-911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVIM.12351

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261331121

http://www.w3.org/2001/XMLSchema#string

P698

24698600

http://www.w3.org/2001/XMLSchema#string

P921

P932

4895454

http://www.w3.org/2001/XMLSchema#string